Issue 18, 2015

Multifunctional Nd3+-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment

Abstract

Core–shell structured Nd3+-sensitized NaYF4:Yb/Nd/Er@NaYF4:Nd@mSiO2 nanoparticles (NPs) were designed and synthesized. The NaYF4:Yb/Nd/Er@NaYF4:Nd core imparts the nanomaterials with luminescence properties for upconversion optical imaging under 808 nm laser irradiation, whereas the mesoporous SiO2 shell allows the nanomaterials to be loaded with anticancer drug doxorubicin (DOX). In vivo toxicity assessment has confirmed that the NPs have low systematic toxicity in healthy mice. In vivo antitumor activity shows that the nanocomposites exhibit greater antitumor efficacy than pure DOX. As a result, the composite nanomaterials can serve as nanotheranostic materials for synchronous upconversion luminescence imaging under 808 nm laser irradiation, and as anticancer drug delivery vehicles, so as to integrate the diagnosis and treatment of cancers in vivo.

Graphical abstract: Multifunctional Nd3+-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment

Article information

Article type
Paper
Submitted
05 Feb 2015
Accepted
31 Mar 2015
First published
02 Apr 2015

Nanoscale, 2015,7, 8574-8583

Multifunctional Nd3+-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment

Y. Chen, B. Liu, X. Deng, S. Huang, Z. Hou, C. Li and J. Lin, Nanoscale, 2015, 7, 8574 DOI: 10.1039/C5NR00829H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements